|Virbac has introduced Carprox Vet®, a carprofen-based NSAID indicated for the alleviation of post-operative pain and inflammation following orthopaedic and soft tissue surgery in dogs and cats and for the treatment of chronic pain and inflammation in dogs.
Carprox is presented as a palatable tablet for dogs in three sizes – 20 mg, 50 mg and 100 mg. An injectable 50 mg/ml solution for dogs and cats has also been launched (in bottles of 20ml).
Virbac Marketing Manager for Companion Animals Simon Boulton MRCVS comments: “We launched our meloxicam-based solution for acute and chronic pain, Inflacam®, in 2013. With the arrival of Carprox Vet, we are now able to offer vets a carprofen-based alternative for added flexibility and choice. We are delighted to add it to our product range and are proud to say that Virbac now offers one of the widest ranges of products for the treatment of small animals in the UK.”
Founded by a veterinary surgeon, Virbac is dedicated to supporting the veterinary profession through the development of innovative products and services, which help animals to lead longer, healthier lives. One of the largest independent veterinary pharmaceutical companies in the world, its wide product portfolio includes many market-leading and award-winning products for large and small animals.
Virbac aims to works in close partnership with its customers, providing the advice and support they need to run successful, profitable businesses. Many of the services it offers are available through its innovative practice support portal www.my-virbac.co.uk.